A61P 11 - Drugs for disorders of the respiratory system

Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
12/2002
12/05/2002	CA2448148A1 Carbohydrate-associated proteins
12/05/2002	CA2448086A1 An adenosine a2a receptor agonist and an anticholinergic agent in combination for treating obstructive airways diseases
12/05/2002	CA2448081A1 Medicinal compositions
12/05/2002	CA2448068A1 Drug preparations
12/05/2002	CA2448062A1 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals
12/05/2002	CA2448023A1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments
12/05/2002	CA2447879A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof
12/05/2002	CA2447475A1 Hydantion derivatives as inhibitors of matrix metalloproteinases
12/05/2002	CA2446723A1 Antibodies that immunospecifically bind to trail receptors
12/05/2002	CA2446613A1 A pde 4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseases
12/05/2002	CA2445650A1 Combination of a dopamine d2-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways
12/05/2002	CA2443713A1 Proteins associated with cell growth, differentiation, and death
12/05/2002	CA2443346A1 Anticholinergic compounds and methods of use
12/04/2002	EP1262183A1 Use of norastemizole for the treatment of allergic rhinitis
12/04/2002	EP1262182A2 Methods and compositions for treating hypertension, angina and other disorders using optically pure(-) amlodipine
12/04/2002	EP1262176A1 Method of treating or inhibiting neutrophil chemotaxis by administering a mek inhibitor
12/04/2002	EP1261714A2 Muteins of interleukin-13 (il-13)
12/04/2002	EP1261712A2 Proteins named fctrx and nucleic acids encoding same
12/04/2002	EP1261640A2 Inflammation-related gene
12/04/2002	EP1261636A2 Human protein kinases and protein kinase-like enzymes
12/04/2002	EP1261635A1 Human polynucleotides, polypeptides, and antibodies
12/04/2002	EP1261605A1 Benzoxazole derivatives as tnf and pde iv inhibitors
12/04/2002	EP1261601A1 Substituted indoles for modulating nfkb activity
12/04/2002	EP1261600A1 Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2
12/04/2002	EP1261595A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
12/04/2002	EP1261590A1 Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
12/04/2002	EP1261585A1 Substituted indole mannich bases
12/04/2002	EP1261583A1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES
12/04/2002	EP1261579A1 Dehydroamino acids
12/04/2002	EP1261379A2 Genetic modification of the lung as a portal for gene delivery
12/04/2002	EP1261378A2 Biodegradable immunomodulatory formulations and methods for use thereof
12/04/2002	EP1261377A2 Immunomodulatory formulations and methods for use thereof
12/04/2002	EP1261359A2 An improved herbal composition having antiallergic properties and a process for the preparation thereof
12/04/2002	EP1261337A2 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors
12/04/2002	EP1261336A2 Il-8 receptor antagonists
12/04/2002	EP1261333A1 Method of treating and diagnosing sleep disordered breathing and means for carrying out the method
12/04/2002	EP1261331A1 Method and compositions for treating fibrotic diseases
12/04/2002	EP1261329A2 Il-8 receptor antagonists
12/04/2002	EP1261328A1 Il-8 receptor antagonists
12/04/2002	EP1261327A2 Adenosine receptor modulators
12/04/2002	EP1261309A1 Device for calculating elixir doses appropriate for a patient's weight
12/04/2002	EP1097139B1 Quinoline derivatives
12/04/2002	EP1073417B1 Pharmaceutical aerosol formulation
12/04/2002	EP0928291B1 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
12/04/2002	EP0719285B1 Il8 inhibitors
12/04/2002	EP0517817B1 Inhibitors of catalytic antibodies
12/04/2002	CN1383386A Drug delivery device for insertion in vagina, rectum of nasal cavity
12/04/2002	CN1382685A Process for preparing R-salbutamol tartrate
12/04/2002	CN1382472A Process for preparing antitussive medicine
12/04/2002	CN1382467A Throat bill
12/04/2002	CN1382451A Application of bamboo rat's serum and medicine containing said serum
12/03/2002	US6489365 Ltb4-antagonistic compounds for treatment of inflammation, allergy or gastropathy induced by non-steroidal antiinflammatory agents in a warm-blooded animals
12/03/2002	US6489339 C3A receptor ligands
12/03/2002	US6489338 Imidazopyridine and imidazopyrimidine antiviral agents
12/03/2002	US6489332 A1 adenosine receptor antagonists
12/03/2002	US6489328 Heterocyclic compounds useful as inhibitors of tyrosine kinases
12/03/2002	US6489327 Tryptase inhibitors
12/03/2002	US6489315 Cyclic compounds, their production and use
12/03/2002	US6489296 Treatment of hypercoagulable states or acquired protein c deficiency with activated protein c, a highly selective therapeutic agent with a low potential for causing bleeding complications
12/03/2002	US6488960 Corticosteroid formulation
12/03/2002	US6488032 Method of providing cosmetic/medical therapy
12/03/2002	CA2216617C New flavone derivatives, their preparation procedures and the pharmaceutical compositions containing them
12/03/2002	CA2213198C Gene therapy by anti-tgf-b agents
12/03/2002	CA2126103C Transfection of lung via aerosolized transgene delivery
12/03/2002	CA2065644C Pyrazolopyridine compound and processes for preparation thereof
11/2002
11/28/2002	WO2002095391A1 Methods and formulations for increasing the affinity of a1 adenosine receptor ligands for the a1 adenosine receptor
11/28/2002	WO2002095067A2 INTERFERON α-14 POLYMORPHISM
11/28/2002	WO2002095011A2 Inactivation of genes of the mep pathway
11/28/2002	WO2002094997A2 Transcriptional regulation of target genes
11/28/2002	WO2002094876A2 Methods and compositions for treating respiratory mucin production associated disease conditions
11/28/2002	WO2002094830A2 DIHYDROPYRROLO[1,2-A]INDOLE AND TETRAHYDROPYRIDO[1,2-a]-INDOLE DERIVATIVES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS
11/28/2002	WO2002094825A1 Novel spiropiperidine derivative
11/28/2002	WO2002094824A1 Pyridopyrimidine compounds and their uses
11/28/2002	WO2002094823A1 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors
11/28/2002	WO2002094821A1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
11/28/2002	WO2002094813A1 Novel pyridyl cyanoguanidine compounds
11/28/2002	WO2002094811A1 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002	WO2002094810A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002	WO2002094808A1 Imidazole-2-carboxamide derivatives as raf kinase inhibitors
11/28/2002	WO2002094786A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
11/28/2002	WO2002094783A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002	WO2002094754A1 Vitamin d analogues
11/28/2002	WO2002094304A1 The use of a gatran for the manufacture of a medicament for the treatment of pulmonary fibrosis
11/28/2002	WO2002094296A1 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
11/28/2002	WO2002094287A2 Identifying parasitic fungi of the organism, and treatment thereof
11/28/2002	WO2002094283A2 Use of phospholipids in the treatment of degenerative lung disease such as copd or cystic fibrosis and to enhance delivery of drugs
11/28/2002	WO2002094273A2 Combination of an adenosine a2a-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways
11/28/2002	WO2002094263A2 Caspase inhibitors and uses thereof
11/28/2002	WO2002094258A1 Improved dosage form of n-acetyl cysteine
11/28/2002	WO2002094217A1 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
11/28/2002	WO2002094203A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
11/28/2002	WO2002094192A2 Antibodies against tumor necrosis factor delta (april)
11/28/2002	WO2002094188A2 Methods for regulating bacteria
11/28/2002	WO2002094180A2 Pharmaceutically active isoindoline derivatives
11/28/2002	WO2002094176A2 Use of compounds with combined nep/mp-inhibitory activity on the preparation of medicaments
11/28/2002	WO2002094019A1 Highly purified antiendotoxin compound
11/28/2002	WO2002085897A8 Heterocyclic compounds for aging-related and diabetic vascular complications
11/28/2002	WO2002083712A8 Transporters and ion channels
11/28/2002	WO2002080887A3 Timed pulse release composition
11/28/2002	WO2002080859A3 Inhalation drug combinations

1 ... 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 ... 878